Predicted to enable deubiquitinase activity and metallopeptidase activity. Predicted to contribute to translation initiation factor activity. Predicted to be involved in negative regulation of proteasomal ubiquitin-dependent protein catabolic process and translational initiation. Predicted to be part of eukaryotic 43S preinitiation complex and eukaryotic translation initiation factor 3 complex, eIF3m. Predicted to be active in polysomal ribosome. Human ortholog(s) of this gene implicated in breast cancer; prostate cancer; and prostate carcinoma. Orthologous to human EIF3H (eukaryotic translation initiation factor 3 subunit H). [provided by Alliance of Genome Resources, Apr 2022]